Diaphragm
FDA grants premarket approval to diaphragm activation system for ventilated adults
The FDA has granted premarket approval to the AeroPace System, which helps mechanically ventilated adults of at least 96 hours wean off ventilation through temporary diaphragm activation, according to a company press release.
Inspiratory muscle training improves muscle endurance, dyspnea following COVID-19
SAN DIEGO — Individuals with inspiratory muscle weakness 2 years after COVID-19 hospitalization had improvement with inspiratory muscle training, according to research presented at the American Thoracic Society International Conference.
Top news of July: OSA combination drug, COVID-19 diaphragm muscle weakness
Healio has compiled the most-read news in pulmonology posted in July.
Diaphragm muscle weakness linked to persistent shortness of breath following COVID-19
Fifteen months following COVID-19 hospitalization, both ventilated and nonventilated patients displayed diaphragm muscle weakness, according to results published in American Journal of Respiratory and Critical Care Medicine.
FDA grants premarket approval to diaphragm pacing system
Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which aids adults with spinal cord injuries that require ventilation to breathe, according to a company press release.